_1777294237270_124456903.png&w=48&q=75){kind=small}
Fondaio Approved for Obesity Treatment
The Saudi Food and Drug Authority announced the approval of the registration of the medication "Fondaio" for the treatment of obesity and weight gain accompanied by health risk factors. This approval follows the completion of all assessment requirements to ensure quality, effectiveness, and safety. The medication, owned by Eli Lilly, is used in cases of obesity associated with health risks and must only be taken under medical supervision according to medical guidelines. Patients are advised to consult their healthcare providers to determine its suitability for their individual health condition. This approval aims to provide a reliable treatment option that contributes to improving patients' health and reducing complications related to excess weight.
Notice: This Is an AI-Generated Summary
Comments (0)